Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345


Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry.

Peacock WF, Costanzo MR, De Marco T, Lopatin M, Wynne J, Mills RM, Emerman CL; ADHERE Scientific Advisory Committee and Investigators.

Cardiology. 2009;113(1):12-9. doi: 10.1159/000164149. Epub 2008 Oct 17.


Treatment of acute decompensated heart failure: harmful effects of high doses of loop diuretics?

Andersen GØ.

Cardiology. 2009;113(1):9-11. doi: 10.1159/000164148. Epub 2008 Oct 17. No abstract available.


Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.

Thomson MR, Nappi JM, Dunn SP, Hollis IB, Rodgers JE, Van Bakel AB.

J Card Fail. 2010 Mar;16(3):188-93. doi: 10.1016/j.cardfail.2009.11.005. Epub 2010 Jan 6.


Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.

Maisel AS, Peacock WF, McMullin N, Jessie R, Fonarow GC, Wynne J, Mills RM.

J Am Coll Cardiol. 2008 Aug 12;52(7):534-40. doi: 10.1016/j.jacc.2008.05.010.


Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.

Wu MY, Chang NC, Su CL, Hsu YH, Chen TW, Lin YF, Wu CH, Tam KW.

J Crit Care. 2014 Feb;29(1):2-9. doi: 10.1016/j.jcrc.2013.10.009. Epub 2013 Oct 29. Review.


Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.

Freda BJ, Slawsky M, Mallidi J, Braden GL.

Am J Kidney Dis. 2011 Dec;58(6):1005-17. doi: 10.1053/j.ajkd.2011.07.023. Epub 2011 Oct 19. Review.


In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).

Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group.

J Am Coll Cardiol. 2005 Jul 5;46(1):57-64.


Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.

Giamouzis G, Butler J, Starling RC, Karayannis G, Nastas J, Parisis C, Rovithis D, Economou D, Savvatis K, Kirlidis T, Tsaknakis T, Skoularigis J, Westermann D, Tschöpe C, Triposkiadis F.

J Card Fail. 2010 Dec;16(12):922-30. doi: 10.1016/j.cardfail.2010.07.246.


Diuretic dosing in acute decompensated heart failure: lessons from DOSE.

Campbell PT, Ryan J.

Curr Heart Fail Rep. 2012 Sep;9(3):260-5. doi: 10.1007/s11897-012-0094-8. Review.


Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.

Yilmaz MB, Gayat E, Salem R, Lassus J, Nikolaou M, Laribi S, Parissis J, Follath F, Peacock WF, Mebazaa A.

Eur J Heart Fail. 2011 Nov;13(11):1244-52. doi: 10.1093/eurjhf/hfr121.


Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP; ADHERE Scientific Advisory Committee and Investigators.

Am Heart J. 2005 Feb;149(2):209-16.


Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD).

Hamaguchi S, Kinugawa S, Tsuchihashi-Makaya M, Goto D, Yamada S, Yokoshiki H, Takeshita A, Tsutsui H; JCARE-CARD Investigators.

Circ J. 2012;76(8):1920-7. Epub 2012 May 26.


Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?

De Vecchis R, Ciccarelli A, Pucciarelli A.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):571-4. doi: 10.2459/JCM.0b013e32833d37b9. Review.


Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.

Chiong JR, Cheung RJ.

Clin Cardiol. 2010 Jun;33(6):345-52. doi: 10.1002/clc.20771. Review.


Clinical features and outcome in hospitalized heart failure in Japan (from the ATTEND Registry).

Sato N, Kajimoto K, Keida T, Mizuno M, Minami Y, Yumino D, Asai K, Murai K, Muanakata R, Aokage T, Sakata Y, Mizuno K, Takano T; TEND Investigators.

Circ J. 2013;77(4):944-51. Epub 2013 Mar 15.


Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.

Aziz EF, Alviar CL, Herzog E, Cordova JP, Bastawrose JH, Pamidimukala CK, Tojino A, Park TS, Musat D, Kukin M.

Hellenic J Cardiol. 2011 May-Jun;52(3):227-35.


Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.

Núñez J, Núñez E, Miñana G, Bodí V, Fonarow GC, Bertomeu-González V, Palau P, Merlos P, Ventura S, Chorro FJ, Llàcer P, Sanchis J.

Eur J Heart Fail. 2012 Sep;14(9):974-84. doi: 10.1093/eurjhf/hfs090. Epub 2012 Jun 14.

Supplemental Content

Support Center